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S U M M A R Y
Objectives: We describe an outbreak of spotted fever group (SFG) rickettsiosis that occurred in 2007 in a
farming community in southeastern Guatemala. We identiﬁed 17 cases of an acute febrile illness, among
which 10, including two fatalities, were conﬁrmed or probable cases of rickettsial disease (case–fatality
proportion 12%).
Methods: PCR, a microimmunoﬂuorescence assay (IFA), and Western blotting were performed on
patient samples, and PCR was performed on ticks.
Results: Using an indirect IFA, seven of 16 (44%) ill persons tested had both IgM and IgG antibodies
reacting with one or more Rickettsia spp antigens; the other nine (56%) had only IgM titers or were
seronegative. Antibodies to SFG protein and lipopolysaccharide were detected by Western blotting with
antigens of Rickettsia typhi, Rickettsia rickettsii, and Rickettsia akari. Only one sample, from an ill person
who died, tested positive by PCR for a SFG Rickettsia. PCR analysis of Amblyomma cajennense ticks from
domestic animals in the area detected the presence of SFG Rickettsia DNA in one of 12 ticks collected.
Conclusions: Further studies in Guatemala are warranted to establish the prevalence of rickettsioses and
to fully characterize the identity of the etiologic agents and vectors.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Contents lists available at SciVerse ScienceDirect
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In the Americas, several rickettsiae of the spotted fever group
(SFG) are endemic and pathogenic. The best known of these are
Rickettsia rickettsii, the cause of Rocky Mountain spotted fever§ The data reported in this manuscript were presented in part at the 57th Annual
Meeting of the American Society for Tropical Medicine and Hygiene, New Orleans,
December 7–11, 2008.
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1 Jiann-Ping Hsu College of Public Health, Georgia Southern University, 501
Forest Dr., Statesboro, GA 30458, USA.
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http://dx.doi.org/10.1016/j.ijid.2012.11.011(RMSF), Rickettsia akari, the cause of rickettsialpox, and Rickettsia
felis, the agent of ﬂea-borne spotted fever.1–5 Recently, another
species of SFG, Rickettsia parkeri, has been found to cause an
eschar-associated rickettsiosis in the USA and in South America.6–8
The application of more versatile and accurate molecular tools for
the identiﬁcation of rickettsiae from human specimens and
ectoparasite samples has permitted the identiﬁcation of new
rickettsial agents and new tick vectors implicated in the
transmission of various rickettsiae, thus expanding our knowledge
of both the types of disease caused by rickettsiae and the
geographic range of rickettsioses.
Although R. rickettsii causing RMSF has been found in Mexico,
Costa Rica, and Panama, where the disease is known as ‘ﬁebrenal Society for Infectious Diseases.
M.E. Eremeeva et al. / International Journal of Infectious Diseases 17 (2013) e304–e311 e305manchada’,9–12 the presence and characteristics of rickettsiae in
Guatemala have not been well studied.In 1898, an outbreak of
epidemic louse-borne typhus was reported from Quetzaltenango,
which continued to experience small outbreaks of this disease
between 1943 and 1956.13 Vaccination, sanitation, and louse-
control measures apparently eliminated epidemic typhus by
1959.13,14 Subsequent surveillance identiﬁed epidemic typhus in
several municipalities of Quetzaltenango between 1970 and
1972;13 however, some of these later cases may have represented
recrudescent Brill–Zinsser disease. To date, neither SFG rickettsiae
nor clinical cases resembling RMSF have been reported from
Guatemala.
We describe an outbreak of febrile illness in the peri-urban
farming community of Moyuta in the Department of Jutiapa,
Guatemala. The outbreak occurred from March to May 2007 and
resulted in illness in 17 persons, with two deaths. Here, we presentFigure 1. Guatemala and neighboring countries. Tevidence that 10 of the 17 patients apparently suffered from a
rickettsial disease.
2. Materials and methods
2.1. Epidemiological investigation
Moyuta is a peri-urban community approximately 80 km from
the capital, Guatemala City, in the department of Jutiapa on the
border with El Salvador, situated at 1283 m above sea level
(Figure 1). The maximum daily temperature averages 34 8C and
minimum temperature 21 8C, with minimal seasonal variations.
Total annual rainfall averages 1400 mm per year, with one rainy
season between May and October. The small town of 17 499
inhabitants is surrounded by pastures and farmland and is served
by one health center. On May 16, 2007, the Health Area of Jutiapa
was informed of the second of two deaths in the previous monthhe location of Moyuta is shown on the map.
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dairy farm. The Guatemala National Health Laboratory performed
preliminary testing, and the presence of signiﬁcantly high levels of
IgG and IgM antibodies reacting to Rickettsia typhi and R. rickettsii
antigens was detected using an indirect microimmunoﬂuores-
cence assay (IFA) in the blood of four ill persons, including the ﬁrst
fatality (Castillo, unpublished data). To identify the etiologic agent
and prevent further cases, the Guatemalan Ministry of Public
Health and Social Welfare (Ministerio de Salud Pu´blica y Asistencia
Social, MSPAS), along with the Health Area of Jutiapa and the
Centers for Disease Control and Prevention (CDC) Regional Ofﬁce
for Central America and Panama, initiated an investigation to
identify additional cases. This effort involved identifying additional
suspect cases, collecting appropriate biological samples from ill
persons and domestic and wild animals, collecting ectoparasites,
and conducting laboratory diagnostics.
For the purposes of this outbreak investigation, a case was
deﬁned as fever and headache in a resident of the neighborhood
surrounding the dairy farm (population 763) between March 1 and
May 16, 2007. Household interviews were conducted in all 197
houses in the neighborhood using a questionnaire addressing type
and duration of symptoms, demographic characteristics of the ill
persons and their occupations, and their domestic, peri-domestic,
or occupational exposure to pets, domestic animals, rodents, and
ectoparasites.
2.2. Collection of specimens from ill persons
When possible, acute and convalescent ethylenediaminete-
traacetic acid (EDTA) whole blood, serum and/or plasma were
obtained from each resident meeting the case deﬁnition. For each
serum sample, an aliquot was shipped to the Guatemala National
Health Laboratory (Guatemala City, Guatemala) and the remainder
was frozen at 70 8C and shipped to the CDC, Atlanta, Georgia, USA,
for further testing.
2.3. Collection of ectoparasites and animal samples
Domestic animals (cows, horses, dogs, and cats) were examined
for ticks and ﬂeas; ectoparasites were collected and refrigerated in
cryovials until they could be frozen at 70 8C and shipped to CDC in
Atlanta. Flagging for ticks was conducted in the ﬁelds surrounding
the dairy farm where the two deceased individuals had worked, as
well as in the cow barns where they milked cows. One hundred live
traps were placed around the farm to capture small mammals.
2.4. Serological procedures
Seroreactivity to rickettsial antigens was evaluated with an IFA
assay conducted according to standard procedures, and further
conﬁrmed by Western blotting (WB). R. rickettsii strain Sheila
Smith and R. typhi Wilmington grown in embryonated chicken
eggs and R. akari MK cultivated in African green monkey kidney
(VERO) cells were used as antigens, as previously described.15 For
the IFA, ﬂuorescein isothiocyanate (FITC)-labeled, goat anti-human
IgG (gamma-chain speciﬁc) and anti-human IgM (mu-chain
speciﬁc) antibodies (Kirkegaard and Perry Laboratories, Gaithers-
burg, MD) were used at dilutions of 1:200 and 1:100, respectively.
For the detection of IgM antibodies, IgG was absorbed with a Mini
Rapi-Sep-M kit in accordance with the manufacturer’s instructions
(Panbio Diagnostics, Columbia, MD). Samples were tested at
consecutive twofold serum dilutions starting at 1:32, and titers
were represented as the reciprocal of the last dilution exhibiting
reactivity with a speciﬁc antigen. IgG and IgM titers 64 were
considered positive for this investigation.For WB, rickettsial cells puriﬁed from host cell debris were
solubilized at room temperature and separated through 10%
sodium dodecyl sulfate (SDS) polyacrylamide gels, as described
previously,15 and were transferred to 45 mm nitrocellulose
membranes (Schleicher and Schuell Bioscience Inc., Keene, NH).
Non-speciﬁc protein binding sites were blocked with 5% non-fat
dry milk, followed by incubation with serum diluted at 1:100 and
then with horseradish peroxidase (HRP)-labeled goat anti-human
IgG (gamma-chain speciﬁc) and IgM Fc5 m antibody (Chemicon-
Millipore) at 1:2500 dilution. Bound enzyme was detected by
reaction with substrate solution containing 0.015% 4-chloro-1-
naphthol (Bio-Rad, Hercules, CA), 0.015% hydrogen peroxide, and
16.7% methanol in 0.02 M Tris-buffered solution (pH 7.5). The
developed membranes were washed in water, dried between ﬁlter
papers, and digitized. All serological tests were repeated twice and
identical results were obtained on different dates by two different
technicians.
2.5. PCR analysis of human specimens
DNA was extracted from 200 ml of EDTA-whole blood using a
QIAamp DNA Mini Kit (Qiagen, Valencia, CA). When blood
specimens were not available, serum or plasma was centrifuged
for 10 min at 14 000  g and the resulting pellet, suspended in
200 ml of homologous supernatant, was used for DNA extraction.
PCR assays for the rickettsial 17 kDa antigen gene were used for
the detection of spotted fever and typhus group Rickettsia DNA
using Amersham Ready-to-Go-Beads (Amersham Biosciences,
Piscataway, NJ) or Qiagen Master Mix (Qiagen), as described
elsewhere.6,16 Semi-nested ampliﬁcation of the 70–602 nt
fragment of the rickettsial outer membrane protein (OmpA)
gene was performed for species identiﬁcation of the SFG
rickettsiae.17 Genomic DNA of Rickettsia prowazekii, Rickettsia
slovaca, or R. rickettsii was used as a positive control for the PCR
assays. Ampliﬁcation of ompB, sca4, and gltA was performed as
described elsewhere; ampliﬁed fragments were sequenced and
analyzed as described previously.17 Sequences generated in this
study were submitted to the NCBI GenBank under the following
accession numbers: 17 kDa protein gene: JF437645; OmpA gene:
JF437646.
2.6. Laboratory conﬁrmed case deﬁnitions
A clinical case of acute febrile illness was considered a probable
case of rickettsiosis if there was a single positive titer from either
acute or convalescent serum. A conﬁrmed case of rickettsiosis was
a positive PCR result or a fourfold increase in titer between acute
and convalescent sera.
2.7. Testing of tick specimens
Ticks were identiﬁed to the genus using standard taxonomic
keys.18 Morphological identiﬁcation of Amblyomma cajennense
ticks was conﬁrmed by direct sequencing of the mitochondrial 12S
ribosomal DNA gene (GenBank accession number JF437644), as
described previously.19
Amblyomma tick DNA was extracted using the QiaMiniAmp Kit
(Qiagen) following the manufacturer’s instructions, eluted with
200 ml AE elution buffer and stored at 4 8C before testing.
Rhipicephalus microplus DNA was extracted using the Wizard SV
96 Genomic DNA Puriﬁcation System (Promega, Madison, WI) and
a Biomek 2000 Robotic Workstation (Beckman Coulter, Fullerton,
CA), and was eluted with 120 ml sterile nuclease-free water.20 PCR
testing for typhus and SFG rickettsiae was performed as described
above.
Table 1
Clinical and epidemiological characteristics of ill persons from Moyuta, Department of Jutiapa, Guatemala
Patient
ID
Sex Age Occupation Date of
onset
Symptoms (days of duration)a Sought medical
attention/
hospitalization
(days)
Treatment
(days)
Exposure factors Outcomeb Categoryc
Fever Headache Chills Myalgia Nausea/
vomiting
Rash Abdominal
pain
Animal
contact
Arthropod
contact
1 F 24 Teacher 3/15/2007 Yes (4) Yes (5) Yes Yes None None Yes (5) Yes/no Amoxicillin,
acetaminophen
Dogs, cats,
rats
NR R P
2 F 68 Housewife 3/25/2007 Yes Yes Yes No None None Yes NR NR Rats NR R P
3 M 34 Farm worker 4/10/2007 Yes (3) Yes (3) Yes (2) No No/yes (4) None None Yes/no Amoxicillin (2) Rats, dogs,
chickens,
cows
Flea bites R P
4 F 39 Housewife 4/10/2007 Yes (5) Yes (3) Yes (6) Yes None Petechial (5) None Yes/no None Dogs, cats,
chickens,
sheep
Flea bites R P
5 M 36 Farm worker 4/13/2007 Yes (4) Yes (6) None NR No/yes (1)d Petechial (6) None Yes/no Amoxicillin
(1 dose)
Rats, dogs,
chicken
Flea bites D P
6 F 2 Child 4/19/2007 Yes (7) Yes (7) Yes (7) No Yes (1)/no Maculopapular
(9)
None Yes/no Acetaminophen Rats, dogs,
chickens
None R P
7 M 23 Farm worker 4/20/2007 Yes (4) Yes (5) Yes (5) No Yes (4)/no None Yes (4) No/no Aspirin (8) Dogs, rats NR R N
8 M 8 Student 4/20/2007 Yes (18) Yes (12) Yes (9) No Yes (4)/yes
(4)
Macular (20) Yes (6) Yes/yes (9) Penicillin,
erythromycin,
doxycycline (9)
Dogs,
chickens,
rats
NR R P
9 M 78 Farm worker 4/22/2007 Yes (18) Yes (6) Yes (6) Yes None None Yes (6) No/no Acetaminophen Rats, dogs,
chickens
NR R P
10 M 7 Student 4/28/2007 Yes (16) Yes (4) None Yes None None None Yes/no Trimethoprim (7) Rats None R N
11 M 23 Farm worker 5/2/2007 Yes (15) Yes (4) None NR Yes (4)/no None None No/no None Rats, dogs NR R N
12 F 18 Housewife 5/5/2007 Yes (2) Yes (2) Yes (2) Yes (2) None None None Yes/no Acetaminophen Dogs None R N
13 M 17 Farm worker 5/5/2007 Yes (9) Yes (9) Yes (5) No Yes (6)/yes
(6)
Petechial (2) None Yes/yes (1) Doxycycline
(1 dose)
Dogs, cows Flea bites D C
14 F 47 Housewife 5/9/2007 Yes Yes Yes Yes None None None NR NR Dogs, pigs NR R N
15 F 18 Librarian 5/12/2007 Yes (5) Yes (2) Yes (3) No Yes (2)/no None None Yes/no Diclofenac,
ibuprofen
Rats Flea bites R N
16 F 28 Housewife 5/12/2007 Yes (2) Yes (3) Yes (1) NR NR NR NR Yes/no Doxycycline (3) Rats, dogs,
chickens
NR R P
17 F 11 Student 5/15/2007 Yes (2) Yes (3) None Yes (3) Yes (1)/no None None Yes/no Doxycycline (2),
acetaminophen
Rats, dogs,
chickens
Flea bites R N
F, female; M, male; NR, no records available.
a Duration of symptoms is provided if records were available.
b R, recovered; D, died.
c P (probable): single positive serology test or convalescent positive IgG and IgM serology with at least one antigen; C (fatal conﬁrmed): PCR-positive; N (recovered suspect): IFA-negative or only IgM-positive serology.
d Patient 5 also experienced diarrhea lasting for 46h.
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Frozen tick samples were thawed and their triturates were
inoculated into a 25-cm2 ﬂask containing a conﬂuent monolayer of
Vero E6 cells (CRL 1587/Vero 76, American Type Culture Collection,
Manassas, VA). Cells were maintained in RPMI-1640 cell culture
medium (Gibco, Invitrogen Corp., Grand Island, NY) supplemented
with 2% fetal bovine serum (HyClone Laboratories Inc., Logan, UT),
5% tryptose phosphate broth, and 1 mM L-glutamine at 32 8C and
34 8C for several passages.17 The presence of rickettsiae was
monitored by PCR and microscopic observation of acridine orange-
stained smears of the cultures.17
3. Results
3.1. Epidemiological and clinical case ﬁndings
Seventeen cases including two fatalities (case–fatality propor-
tion 12%) were identiﬁed between April 10 and May 15, 2007, with
illness onset dates from March 15 through May 15 (Table 1). In
addition to headache and fever, ill persons also reported chills
(76%), nausea (44%), abdominal pain (31%), vomiting (25%), and
rash (31%). Symptoms persisted 1–20 days (median 4 days)
following the onset of illness. A petechial rash with unspeciﬁed
location was present during the illnesses of the two persons who
died (residents 5 and 13) for 6 and 2 days, respectively. Similarly,
petechiae were observed for 5 days in another adult resident
(resident 4) who recovered; two ill children (residents 6 and 8)
developed a maculopapular rash lasting for 9 and 20 days,
respectively, that persisted for several days following resolution of
fever. Eschar or eschar-like lesions were not reported for the two
persons who died, nor were they noticed by the other patients in
their retrospective self-reporting.
Of the 17 ill persons, eight (47%) were male, including the two
fatalities. Their median age was 23 years (range 2–78 years). Six
(35%) worked on the same dairy farm and 12 (71%) lived in the
residential area of the farm. The two fatalities occurred in men whoTable 2
Laboratory assessment of serum and blood specimens for antibodies reacting against r
Patient ID Days after onset PCRa
RT 
1 56 Neg (P) 256 
2 46 Neg (P) 512 
3 NR Neg (S) 128 
4 31 Neg (P) 512 
49 NT 1024 
5c NR NT NT 
6 22 NT 128 
40 NT 64 
7 25 Neg (P) 32 
8 25 Neg (P) 256 
38 NT 512 
9 24 Neg (P) 32 
10 18 NT <32 
11 16 Neg (P) 64 
12 18 Neg (P) 32 
13 5 Pos (P) 32 
7 Neg (S) 32 
14 5 Neg (P) 64 
15 2 Neg (P) <32 
13 NT 64 
16 2 Neg (P) 32 
17 3 Neg (P) 32 
16 NT 64 
CDC, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; NR, not record
a P, plasma pellet; S, serum pellet; NT, not tested because of insufﬁcient sample, no
b Reciprocal IgM and IgG titers against antigen of R. typhi (RT), R. rickettsii (RR), and
c Samples from patient 5 were not available for testing at the CDC.had been employed to milk the dairy cows; the second man had
been hired to replace the ﬁrst man after his death. Fourteen (82%)
ill persons had known exposure to animals living on the farm,
including cows, pigs, dogs, and chickens. Fifteen (88%) ill persons
reported seeing rats during the day and/or evening hours or being
bitten by ﬂeas, or both. The presence of body lice or head lice was
not reported by any ill person; however, respondents acknowl-
edged being able to recognize ticks and seeing them routinely on
animals. Twelve (80%) ill persons sought medical care at the local
health center. Of these, eight received antibiotics, including
amoxicillin (three patients), penicillin (one patient), erythromycin
(one patient), trimethoprim (one patient), and doxycycline (four
patients). One pediatric patient (resident 8) was hospitalized and
treated with three different antibiotics. One of the ill persons who
died (resident 5) was treated with amoxicillin, and the second
(resident 13) received a single dose of doxycycline 1 h before he
died. Five ill persons were given, or self-medicated with
acetaminophen, diclofenac, ibuprofen, and aspirin; two ill persons
recovered without medication.
3.2. Testing of human specimens
At the CDC, serum samples of seven (44%) ill persons tested
positive by IFA for both IgM and IgG antibodies, reacting with
antigens of R. typhi, R. rickettsii, and/or R. akari, with titers ranging
from 64 to 4096 (Table 2). No IFA antibody was detected in two
samples from days 5 and 7 post-onset for the second fatality
(resident 13). The sample from the other fatality (resident 5) tested
IFA-positive for IgG and IgM antibody to R. rickettsii antigen at the
Guatemala National Laboratory (Castillo, unpublished data), but
the sample was not available for conﬁrmatory testing at CDC. Sera
of seven tested ill persons (44%) had only low IgM titers to one or
more antigens, and elevated IgM antibody reacting with R. akari
antigen was only present in the serum of one of these persons
(resident 16). IgG-reactive sera were collected at 22 to 46 days
after the onset of the febrile illness and were classiﬁed as
convalescent based on the time course of the illnesses. When allickettsiae and for rickettsial DNA by PCR performed at the CDC
IgM-IFAb IgG-IFAb
RR RAK RT RR RAK
512 32 <32 32 64
32 256 1024 <32 1024
256 64 <32 512 <32
1024 128 4096 2048 1024
512 256 32 2048 256
NT NT NT NT NT
256 <32 512 256 128
64 64 <32 128 <32
64 64 <32 <32 <32
128 128 32 <32 512
64 128 256 32 64
64 64 <32 <32 256
64 32 <32 <32 <32
<32 64 <32 <32 <32
<32 32 <32 <32 <32
32 <32 <32 <32 32
<32 32 <32 <32 32
32 64 <32 <32 <32
64 32 <32 32 <32
64 32 <32 <32 <32
<32 256 <32 <32 <32
<32 <32 <32 32 32
64 32 <32 <32 32
ed.
 sample, or sample not suitable for PCR.
 R. akari (RAK).
Figure 2. Western blotting reactivity of representative serum specimens. Panels A and B show the two different patterns of Western blotting reactivity observed in IFA-
positive persons: resident 4 (panel A) and resident 8 (panel B). Arrows indicate the positions of the protein molecular weight markers with the following sizes, from the top to
the bottom: 116 kDa, 84.8 kDa, 53.9 kDa, 37.4 kDa, and 29.0 kDa (Bio-Rad). The following antigen abbreviations are used: A, R. akari; R, R. rickettsii; T, R. typhi.
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directed against high molecular weight surface protein antigens
(110 kDa) of each of three rickettsiae (Figure 2, A and B). Some
sera exhibited weak IgM antibody reactivity to R. akari and R.
rickettsii lipopolysaccharide (LPS) antigens at approximately 37.4
kDa and strong IgG antibody reactivity against LPS as washboard at
84–32 kDa (Figure 2A). Negative and positive serum controls were
processed for each serologic assay and they performed as expected.
PCR was performed on 15 DNA samples from 14 ill persons
whose blood samples were collected 2 to 56 days after the onset of
illness (Table 2). Only the DNA from a precipitate of the serum of
one of the fatalities (resident 13; day 5 after onset of the illness)
tested positive for SFG rickettsiae using 17 kDa protein gene nested
PCR (GenBank accession number JF437645). The nucleotide
fragment of the fragment ampliﬁed had the greatest similarity
(99%) with the highly conserved homologous gene fragments of
the core SFG rickettsiae and differed from that of R. akari, R. typhi,
and R. prowazekii. Other fragments typically used for molecular
identiﬁcation of Rickettsia, including gltA, ompA, ompB, and sca4,
could not be ampliﬁed.
3.3. Environmental assessment and testing of tick samples
Five rats were trapped during the environmental investigation;
they tested negative by PCR for Leptospira spp. at the Guatemalan
National Laboratory (Castillo, unpublished data).
A. cajennense and R. microplus ticks were collected from a horse
and a cow, respectively, cared for by the two farm workers who
died. No ticks were collected by ﬂagging. Twelve A. cajennense and
85 R. microplus tested negative for DNA of typhus group rickettsiae.
DNA from one A. cajennense tested PCR-positive for the ompA
fragment of SFG rickettsiae. The nucleotide sequences of the ompA
PCR amplicon had the greatest genetic similarity with ompA
sequences of Rickettsia africae and Rickettsia sibirica cluster
(GenBank accession number JF437646). Other fragments of
Rickettsia, including 17 kDa protein gene, gltA, ompB, and sca4,
could not be ampliﬁed from this tick DNA. Inoculation of the
triturate of the PCR-positive tick into Vero cell cultures did not yield
a rickettsial isolate following three consecutive blind passages at
32 8C and 34 8C. No ﬂeas were collected during this investigation.4. Discussion
To our knowledge, we report the ﬁrst conﬁrmed outbreak of
spotted fever rickettsiosis in Guatemala. The diagnosis was made
by identiﬁcation of SFG Rickettsia DNA in a specimen from one of
two persons who worked on the same dairy farm and who died of
an acute febrile illness, and in a tick found on a farm animal. In
total, 17 ill residents with similar clinical manifestations were
identiﬁed from a small community in the Department of Jutiapa
from March through May 2007. Evidence for signiﬁcant rickettsial
exposure (IgG IFA antibodies, PCR, WB) was obtained for 10 of
them, including the two residents who died.
Autopsies were not performed on the two deceased residents.
Serum specimens were only obtained from one of the two
deceased, and no specimens were available for testing at CDC
from the ﬁrst fatal case. The rickettsial etiology of this illness was
conﬁrmed by detection of rickettsial DNA in a specimen of serum
collected on day 5 after onset of illness from the second fatality.
This patient had not seroconverted to rickettsiae when he died on
day 7 of illness. In contrast, IFA tests performed at the Guatemala
National Health Laboratory on serum collected 5 days after onset of
illness from the ﬁrst fatality, detected high titers of antibodies
reacting with both R. typhi and R. rickettsii. Negative testing for
leptospirosis and ehrlichiosis in this patient and in other patients
ruled out other etiologies responsible for this illness (not shown).
Limitations of the samples available for analysis restricted
conﬁrmation of the speciﬁc rickettsial etiologic agent(s) of these
illness(es). Laboratory results were obtained at CDC for 16 ill
persons; however, standard paired acute and early convalescent
serum specimens were available for only two ill persons (residents
15 and 17), who both exhibited only a weak IgM titer of 64 to R.
typhi and R. rickettsii antigens. For other ill persons, only either
acute or convalescent serum specimens were available. One DNA
sample (from one of the fatalities) of the ﬁve DNA samples made
from acute IFA-negative serum specimens tested positive by PCR
for rickettsiae. Microimmunoﬂuorescence (also called IFA) is
presently the gold standard for the serological diagnosis of
rickettsial diseases;21 however, its sensitivity depends on the
timing of sample collection relative to illness onset. Serum samples
obtained early in the infection are often negative or so close to the
M.E. Eremeeva et al. / International Journal of Infectious Diseases 17 (2013) e304–e311e310cutoff limit that results are difﬁcult to interpret; this was the case
for some ill persons in this investigation. The sensitivity of the IFA
is estimated at 94–100% after 14 days of illness, and testing paired
acute and convalescent samples substantially increases conﬁdence
in the results. In the case of less severe rickettsial infections, such
as rickettsialpox and R. parkeri or R. africae infection, convalescent
sera often do not demonstrate signiﬁcant titers until 25–28 days
after the onset of illness.6,22 The duration of antibody persistence
after recovery from infection is also variable. In RMSF, IgG and IgM
antibody titers increase concurrently by the second week of illness,
and IgM antibodies disappear after 3–4 months, whereas IgG titers
may persist from 7–8 months to several years.23,24 Unfortunately,
while we used R. typhi, R. rickettsii, and R. akari as surrogate
antigens for the unknown etiologic agent(s) in this study and
conﬁrmed the presence of antibodies reacting with expected
immunogenic rickettsial antigens in serum specimens by WB, it is
not possible to deﬁne the rickettsial agent responsible for this
seroconversion by serology, nor to exclude the possibility that
titers were pre-existent in ill persons.25,26 In this outbreak,
extensive cross-reactivity was observed with antigens of typhus
and SFG rickettsiae by both IFA and WB. This could be due to a
novel rickettsial species or to multiple exposures to a variety of
rickettsial agents on different occasions during the residents’
lifetimes. Appropriate case–control studies and serological surveys
are needed to characterize exposure to rickettsial agents found in
different regions of Guatemala. We were not able to complete the
molecular identiﬁcation of the rickettsial agent causing this
outbreak due to the lack of appropriate specimens such as whole
blood, skin biopsy collected from the rash area, or autopsy
specimens.
Testing of arthropods collected from residents, pets, or the
immediate environment of the suspected cases may allow the
detection of rickettsial agents. Of the two tick species collected
during this investigation, A. cajennense and R. microplus, only one
Amblyomma tick tested PCR-positive for a SFG Rickettsia and it was
genetically closely related to R. africae and R. sibirica rather than
other more common species like Rickettsia amblyommii.20,27 Until
relatively recently, only A. cajennense, Haemaphysalis leporispalus-
tris, and Rhipicephalus sanguineus were implicated as vectors for
the transmission of R. rickettsii in Mexico and Central America.28–30
However, in Brazil and the USA, a more extensive list of tick species
has been implicated in the natural cycles of many rickettsial agents
pathogenic for humans.1,31–33 Beside A. cajennense, Amblyomma
aureolatum and Amblyomma oblongogutatum are involved in the
natural cycles of R. rickettsii, while R. parkeri has been detected in
Amblyomma triste.27 Furthermore, recently reported SFG rickettsial
agents causing R. parkeri-like illness in Brazilian patients from the
Atlantic rain forest were found in Amblyomma ovale and R.
sanguineus.34 Small to medium size mammals are most frequently
considered as reservoirs for many SFG rickettsiae. On the other
hand, capybaras (Hydrochoerus hydrochaeris), the largest known
rodent, are demonstrated to be a primary reservoir for R. rickettsii
in Brazil.27 Also, a recent study in Mississippi, USA, suggested that
cattle can serve as a transportation mode for the dissemination of
R. parkeri-infected Amblyomma maculatum ticks.35
Preliminary studies indicate that R. felis36 and Rickettsia
hoogstraalii are also present in arthropods from Guatemala
(Estevez and others, unpublished data). Based on experience in
the Yucatan Peninsula,37,38 it is reasonable to expect that cases of
cat ﬂea rickettsiosis may also occur in Guatemala. Whether
differences in the genetic or nutritional status of local human
populations may also inﬂuence the clinical manifestations or
morbidity of rickettsial diseases in Central America remains to be
evaluated.
In conclusion, we report the ﬁrst conﬁrmed outbreak of SFG
rickettsiosis in Guatemala. Our data indicate a need for furtherrickettsial disease surveillance and education of the medical
community about the signs and symptoms of rickettsial diseases
and proper patient management, particularly when fever of
unknown origin is present.
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